Disclosed herein are interleukin (IL) conjugates (e.g., IL-2 conjugates) anduse in the treatment of one or more indications.Also described herein are pharmaceutical compositions and kits comprising oneor more of the interleukin conjugates (e.g.,IL-2 conjugates).